KEMBLE GEORGE sold 24.5% of their position (20.21K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market sale worth $201.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Series A Common Stock
Shares
+9.75K
Price / share
$6.36
Trade value
$62.02K
% of position
Series A Common Stock
Shares
+10.46K
Price / share
$6.36
Trade value
$66.49K
% of position
Series A Common Stock
Shares
−20.21K
Price / share
$9.95
Trade value
$201.15K
% of position
Net shares
+0.00
Net value
-$72.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 8/11/2026 | M · Option Exercise | +9.75K | $6.36 | $62.02K | 15.7% | 62.16K | 71.91K |
| Series A Common Stock Direct | 8/11/2026 | M · Option Exercise | +10.46K | $6.36 | $66.49K | 14.5% | 71.91K | 82.37K |
| Series A Common Stock Direct | 8/11/2026 | S · Sale | −20.21K | $9.95 | $201.15K | 24.5% | 82.37K | 62.16K |
| Total | +0.00 | -$72.64K | ||||||
Stock Option (Right to Buy)
Series A Common Stock
9.75K shares
Shares
−9.75K
Strike price
6.36
Held after
358.07K
Exercisable
—
Stock Option (Right to Buy)
Series A Common Stock
10.46K shares
Shares
−10.46K
Strike price
6.36
Held after
35.98K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Series A Common Stock9.75K shares | 8/11/2026 | M · Option Exercise | −9.75K | 6.36 | — | 358.07K |
| Stock Option (Right to Buy) Direct | Series A Common Stock10.46K shares | 8/11/2026 | M · Option Exercise | −10.46K | 6.36 | — | 35.98K |